 |
|
 |
Hormone Replacment Therapy
The decision to stop one component of the Women's Health Initiative has brought us an important step closer to answering vital questions about hormone replacement therapy, which is used by nearly 40% of postmenopausal women in this country to relieve symptoms of menopause. Scientists have weighed both the risks and benefits of the combined therapy of estrogen plus progestin, and have concluded it could cause more harm than good. Millions of American women are now reconsidering whether to start or continue this commonly used combined therapy.
First and foremost, women should discuss this finding with their health care provider. Second, women should be aware that it is no longer recommended to take this combined therapy to prevent heart disease, and should discuss with their health provider other ways to protect the heart. Third, women who are taking this combined therapy to help prevent osteoporosis should ask their health providers if they are good candidates for alternate treatment, based on their personal health profiles.
August 20, 2002:
More evidence HRT doesn't cut heart risk: study
August 14, 2002:
US officials to reassess value of hormone therapy
July 16, 2002:
Increased Risk of Ovarian Cancer is Linked to Estrogen Replacement Therapy
July 9, 2002:
NHLBI Stops Trial of Estrogen Plus Progestin Due to Increased Breast Cancer Risk, Lack of Overall Benefit
July 9, 2002:
Statement on the Estrogen Plus Progestin Trial of The Women's Health Initiative by The American College of Obstetricians and Gynecologists
For More Information
Information from the National Heart, Lung and Blood Institute
Information from the Women's Health Initiative Participant Website
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women
Failure of Estrogen Plus Progestin Therapy for Prevention
Frequently Asked Questions about Hormone Replacement Therapy
Frequently Asked Questions about Menopause
Frequently Asked Questions about Osteoporosis
Frequently Asked Questions about Aging and Women Getting Older
Frequently Asked Questions about Raloxifene
|
 |
|
 |